These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 181132)

  • 21. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination chemotherapy with a five-drug regimen for invasive thymoma.
    Bjerrum OW; Kiss K; Daugaard G
    Acta Oncol; 1996; 35(1):71-3. PubMed ID: 8619943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy of malignant thymoma. Case report and review of the literature.
    Hu E; Levine J
    Cancer; 1986 Mar; 57(6):1101-4. PubMed ID: 3080220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytostatic chemotherapy in lymphogranulomatosis].
    Stacher A
    Med Klin; 1973 Jul; 68(30):985-8. PubMed ID: 4131695
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chemotherapy of Hodgkin's disease].
    Amiel JL; Mathé G
    Rev Prat; 1974 Oct; 24(45):3957-60, 3963-4, 3967-8. PubMed ID: 4141118
    [No Abstract]   [Full Text] [Related]  

  • 26. CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
    Santoro A; Viviani S; Valagussa P; Bonfante V; Bonadonna G
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):23-6. PubMed ID: 2420012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
    J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remission of invasive thymoma due to chemotherapy. Two patients treated with cyclophosphamide, doxorubicin, and vincristine.
    Loehrer PJ; Bonomi P; Goldman S; Reddy S; Faber LP; Jensik R; Dainauskas JR
    Chest; 1985 Mar; 87(3):377-80. PubMed ID: 3971764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial chemotherapy followed by surgery in malignant thymoma.
    Mackintosh JF; Hawson GA; Matar KS; Johnston NG
    Aust N Z J Med; 1989 Aug; 19(4):362-4. PubMed ID: 2783088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy versus chemoimmunotherapy of head and neck cancer: report of a randomized study.
    Richman SP; Livingston RB; Gutterman JU; Suen JY; Hersh EM
    Cancer Treat Rep; 1976 May; 60(5):535-9. PubMed ID: 62613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Prosnitz LR; Farber LR; Fischer JJ; Bertino JR
    Radiology; 1973 Apr; 107(1):187-93. PubMed ID: 4689429
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
    Bonadonna G; Zucali R; De Lena M; Valagussa P
    Cancer Treat Rep; 1977 Aug; 61(5):769-77. PubMed ID: 70270
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
    Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.
    Bonadonna G; Zucali R; Monfardini S; De Lena M; Uslenghi C
    Cancer; 1975 Jul; 36(1):252-9. PubMed ID: 54209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease.
    Kurnick JE; White M; Ware DE; Robinson WA
    Cancer Chemother Rep; 1975; 59(6):1147-50. PubMed ID: 56989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancer.
    Georgoulias V; Misset JL; Ribaud P; Machover D; De Vassal F; Dorval T; Musset M; Schwarzenberg L; Reizenstein P; Mathe G; Gaget H
    Anticancer Res; 1983; 3(2):107-10. PubMed ID: 6189445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience.
    Berruti A; Borasio P; Gerbino A; Gorzegno G; Moschini T; Tampellini M; Ardissone F; Brizzi MP; Dolcetti A; Dogliotti L
    Br J Cancer; 1999 Nov; 81(5):841-5. PubMed ID: 10555755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Induction of complete remission with adriamycin and cis-platinum in invasive thymoma].
    Mitrou PS; Bergmann L; Tuengerthal S
    Dtsch Med Wochenschr; 1982 Nov; 107(44):1667-70. PubMed ID: 6890437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.